Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation

The new coronavirus SARS-COV-2, which emerged in late 2019 from Wuhan city of China was regarded as causing agent of the COVID-19 pandemic. The primary protease which is also known by various synonymous i.e., main protease, 3-Chymotrypsin-like protease (3CL(PRO)) has a vital role in the replication...

Descripción completa

Detalles Bibliográficos
Autores principales: Samad, Abdus, Ajmal, Amar, Mahmood, Arif, Khurshid, Beenish, Li, Ping, Jan, Syed Mansoor, Rehman, Ashfaq Ur, He, Pei, Abdalla, Ashraf N., Umair, Muhammad, Hu, Junjian, Wadood, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028080/
https://www.ncbi.nlm.nih.gov/pubmed/36959979
http://dx.doi.org/10.3389/fmolb.2023.1060076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028080/
https://www.ncbi.nlm.nih.gov/pubmed/36959979
http://dx.doi.org/10.3389/fmolb.2023.1060076

Ejemplares similares